Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease

Diane Tseng, Leelanand P. Rachakonda, Zheng Su, Ranjana Advani, Sandra Horning, Richard T. Hoppe, Andrew Quon, Edward E. Graves, Billy W. Loo, Phuoc T. Tran

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: We hypothesized that quantitative PET parameters may have predictive value beyond that of traditional clinical factors such as the International Prognostic Score (IPS) among Hodgkin's disease (HD) patients.Methods: Thirty HD patients treated at presentation or relapse had staging and interim-treatment PET-CT scans. The majority of patients (53%) had stage III-IV disease and 67% had IPS ≥ 2. Interim-treatment scans were performed at a median of 55 days from the staging PET-CT. Chemotherapy regimens used: Stanford V (67%), ABVD (17%), VAMP (10%), or BEACOPP (7%). Hypermetabolic tumor regions were segmented semiautomatically and the metabolic tumor volume (MTV), mean standardized uptake value (SUVmean), maximum SUV (SUVmax) and integrated SUV (iSUV) were recorded. We analyzed whether IPS, absolute value PET parameters or the calculated ratio of interim- to pre-treatment PET parameters were associated with progression free survival (PFS) or overall survival (OS).Results: Median follow-up of the study group was 50 months. Six of the 30 patients progressed clinically. Absolute value PET parameters from pre-treatment scans were not significant. Absolute value SUVmax from interim-treatment scans was associated with OS as determined by univariate analysis (p < 0.01). All four calculated PET parameters (interim/pre-treatment values) were associated with OS: MTV int/pre (p < 0.01), SUVmean int/pre (p < 0.05), SUVmax int/pre (p = 0.01), and iSUV int/pre (p < 0.01). Absolute value SUVmax from interim-treatment scans was associated with PFS (p = 0.01). Three calculated PET parameters (int/pre-treatment values) were associated with PFS: MTV int/pre (p = 0.01), SUVmax int/pre (p = 0.02) and iSUV int/pre (p = 0.01). IPS was associated with PFS (p < 0.05) and OS (p < 0.01).Conclusions: Calculated PET metrics may provide predictive information beyond that of traditional clinical factors and may identify patients at high risk of treatment failure early for treatment intensification.

Original languageEnglish (US)
Article number5
JournalRadiation Oncology
Volume7
Issue number1
DOIs
StatePublished - Jan 19 2012

Keywords

  • Hodgkin's disease
  • Metabolic tumor volume
  • PET
  • Quantitative PET parameters
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease'. Together they form a unique fingerprint.

Cite this